| Names | |
|---|---|
| Preferred IUPAC name 6,6,9-Trimethyl-3-propyl-6H-dibenzo[b,d]pyran-1-ol | |
| Other names 6,6,9-Trimethyl-3-propyl-6H-benzo[c]chromen-1-ol | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider |
|
| MeSH | cannabivarin |
| UNII | |
| |
| |
| Properties | |
| C19H22O2 | |
| Molar mass | 282.38 g/mol |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Cannabivarin (CBV), also known ascannabivarol, is considered a non-psychoactive cannabinoid — it does not produce the euphoric side effects found in THC. Minor amounts of CBV are found in the hemp plantCannabis sativa. It is an analog ofcannabinol (CBN) with theside chain shortened by twomethylene bridges (−CH2−). CBV is anoxidation product oftetrahydrocannabivarin (THCV, THV).[1]
It has no double bond isomers nor stereoisomers.
It is not scheduled byConvention on Psychotropic Substances.
CBV is not scheduled at the federal level in theUnited States,[2] but it could be considered an analog (ofTHC), in which case, sales or possession intended for human consumption could be prosecuted under theFederal Analog Act.